Literature DB >> 2218724

Antisense RNA inhibition of HPRT synthesis.

J T Stout1, C T Caskey.   

Abstract

The abundant production of antisense hypoxanthine phosphoribosyltransferase (HPRT) RNA in NIH-3T3, COS, or HeLa cells leads to an inhibition of HPRT synthesis. HPRT enzyme levels in cells transfected with mouse HPRT antisense RNA expression vectors are reduced to less than 1% of parental cell activity, resulting in resistance to 6-thioguanine (6TG). The expression of antisense HPRT RNA leads to a marked reduction in the steady-state levels of endogenous HPRT mRNA. Furthermore, we demonstrate that intron-specific antisense RNA, complementary to sequences adjacent to splice donor or acceptor sites of the first intron of the mouse HPRT gene, are effective in depressing endogenous HPRT levels. These studies suggest that antisense RNA can inhibit gene expression in the nucleus, possibly by perturbing nuclear RNA processing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2218724     DOI: 10.1007/bf01232465

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  4 in total

1.  Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I.

Authors:  J Trojan; B K Blossey; T R Johnson; S D Rudin; M Tykocinski; J Ilan; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.

Authors:  Y Rouillé; G Westermark; S K Martin; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

3.  Destabilization of rbcS sense transcripts by antisense RNA.

Authors:  C Z Jiang; D Kliebenstein; N Ke; S Rodermel
Journal:  Plant Mol Biol       Date:  1994-06       Impact factor: 4.076

4.  Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin.

Authors:  H Li; S K Choudhary; D J Milner; M I Munir; I R Kuisk; Y Capetanaki
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.